Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

Detalhes bibliográficos
Autor(a) principal: Badaro, Roberto José da Silva
Data de Publicação: 1990
Outros Autores: Falcoff, Ernesto, Badaró, Fernando Sérgio da Silva, Carvalho Filho, Edgar Marcelino, Sampaio, Diana da Silva Pedral, Barral, Aldina Maria Prado, Carvalho, Jose S, Barral Netto, Manoel, Brandely, Maud, Silva, Luciana, Bina, Jose Carlos, Teixeira, Rodolfo, Falcoff, Rebeca, Rocha, Heonir, Ho, John L, Johnson Junior, Warren D
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/23126
Resumo: Múltipla - ver em Notas
id CRUZ_869e053f88ff6a12b4eb4217e4849bee
oai_identifier_str oai:www.arca.fiocruz.br:icict/23126
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Badaro, Roberto José da SilvaFalcoff, ErnestoBadaró, Fernando Sérgio da SilvaCarvalho Filho, Edgar MarcelinoSampaio, Diana da Silva PedralBarral, Aldina Maria PradoCarvalho, Jose SBarral Netto, ManoelBrandely, MaudSilva, LucianaBina, Jose CarlosTeixeira, RodolfoFalcoff, RebecaRocha, HeonirHo, John LJohnson Junior, Warren D2017-11-13T14:18:43Z2017-11-13T14:18:43Z1990BADARO, R. J. S. et al. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New England Journal of Medicine, v. 322, n. 1, p. 16-21, 1990.0028-4793https://www.arca.fiocruz.br/handle/icict/2312610.1056/NEJM199001043220104engMassachusetts Medical SocietyLeishmaniose visceralInterferon gamaTratamentoAntimonioVisceral leishmaniasisinterferon gammaTreatmentAntimonyTreatment of visceral leishmaniasis with pentavalent antimony and interferon gammainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleMúltipla - ver em NotasAcute visceral leishmaniasis is associated with an antigen-specific immunosuppression of mononuclear cells as evidenced by defective in vitro production of interferon gamma. We evaluated treatment with recombinant human interferon gamma in combination with conventional pentavalent antimony therapy in patients with visceral leishmaniasis. Six of eight patients with visceral leishmaniasis (mean duration, 17 months) that had been unresponsive to multiple courses of pentavalent antimony responded to treatment with recombinant human interferon gamma (100 to 400 micrograms per square meter of body-surface area per day) in addition to pentavalent antimony (20 mg per kilogram of body weight per day) for 10 to 40 days. The other two patients improved initially but then relapsed and required treatment with amphotericin B. Eight of nine additional patients with previously untreated severe visceral leishmaniasis were also successfully treated with the combination of interferon gamma and pentavalent antimony. The 14 patients who responded to this regimen had marked improvement in symptoms and in measures of anemia and leukopenia, as well as weight gain, a decrease in spleen size, and an absence or reduction of leishmanias in splenic aspirates. These patients had no recurrence of illness after a mean (+/- SE) follow-up of 8 +/- 1 months. Fever was the only major side effect of interferon gamma. We conclude that the combination of interferon gamma and pentavalent antimony is effective in treating seriously ill patients with refractory or previously untreated visceral leishmaniasis.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/23126/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALBadaro RE Treatment of visceral....pdfBadaro RE Treatment of visceral....pdfapplication/pdf1091059https://www.arca.fiocruz.br/bitstream/icict/23126/2/Badaro%20RE%20Treatment%20of%20visceral....pdf874a7b12216807918bd0638e1f726371MD52TEXTBadaro RE Treatment of visceral....pdf.txtBadaro RE Treatment of visceral....pdf.txtExtracted texttext/plain1344https://www.arca.fiocruz.br/bitstream/icict/23126/3/Badaro%20RE%20Treatment%20of%20visceral....pdf.txt0a1c68f679e30cce1e7d7eb269c1b095MD53icict/231262023-03-15 14:34:08.935oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:08Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
title Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
spellingShingle Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
Badaro, Roberto José da Silva
Leishmaniose visceral
Interferon gama
Tratamento
Antimonio
Visceral leishmaniasis
interferon gamma
Treatment
Antimony
title_short Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
title_full Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
title_fullStr Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
title_full_unstemmed Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
title_sort Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
author Badaro, Roberto José da Silva
author_facet Badaro, Roberto José da Silva
Falcoff, Ernesto
Badaró, Fernando Sérgio da Silva
Carvalho Filho, Edgar Marcelino
Sampaio, Diana da Silva Pedral
Barral, Aldina Maria Prado
Carvalho, Jose S
Barral Netto, Manoel
Brandely, Maud
Silva, Luciana
Bina, Jose Carlos
Teixeira, Rodolfo
Falcoff, Rebeca
Rocha, Heonir
Ho, John L
Johnson Junior, Warren D
author_role author
author2 Falcoff, Ernesto
Badaró, Fernando Sérgio da Silva
Carvalho Filho, Edgar Marcelino
Sampaio, Diana da Silva Pedral
Barral, Aldina Maria Prado
Carvalho, Jose S
Barral Netto, Manoel
Brandely, Maud
Silva, Luciana
Bina, Jose Carlos
Teixeira, Rodolfo
Falcoff, Rebeca
Rocha, Heonir
Ho, John L
Johnson Junior, Warren D
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Badaro, Roberto José da Silva
Falcoff, Ernesto
Badaró, Fernando Sérgio da Silva
Carvalho Filho, Edgar Marcelino
Sampaio, Diana da Silva Pedral
Barral, Aldina Maria Prado
Carvalho, Jose S
Barral Netto, Manoel
Brandely, Maud
Silva, Luciana
Bina, Jose Carlos
Teixeira, Rodolfo
Falcoff, Rebeca
Rocha, Heonir
Ho, John L
Johnson Junior, Warren D
dc.subject.other.pt_BR.fl_str_mv Leishmaniose visceral
Interferon gama
Tratamento
Antimonio
topic Leishmaniose visceral
Interferon gama
Tratamento
Antimonio
Visceral leishmaniasis
interferon gamma
Treatment
Antimony
dc.subject.en.pt_BR.fl_str_mv Visceral leishmaniasis
interferon gamma
Treatment
Antimony
description Múltipla - ver em Notas
publishDate 1990
dc.date.issued.fl_str_mv 1990
dc.date.accessioned.fl_str_mv 2017-11-13T14:18:43Z
dc.date.available.fl_str_mv 2017-11-13T14:18:43Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BADARO, R. J. S. et al. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New England Journal of Medicine, v. 322, n. 1, p. 16-21, 1990.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/23126
dc.identifier.issn.pt_BR.fl_str_mv 0028-4793
dc.identifier.doi.none.fl_str_mv 10.1056/NEJM199001043220104
identifier_str_mv BADARO, R. J. S. et al. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New England Journal of Medicine, v. 322, n. 1, p. 16-21, 1990.
0028-4793
10.1056/NEJM199001043220104
url https://www.arca.fiocruz.br/handle/icict/23126
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Massachusetts Medical Society
publisher.none.fl_str_mv Massachusetts Medical Society
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/23126/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/23126/2/Badaro%20RE%20Treatment%20of%20visceral....pdf
https://www.arca.fiocruz.br/bitstream/icict/23126/3/Badaro%20RE%20Treatment%20of%20visceral....pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
874a7b12216807918bd0638e1f726371
0a1c68f679e30cce1e7d7eb269c1b095
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008985244041216